Bio-Key Intl Inc Stock Price, News & Analysis

BIO-key (NASDAQ: BKYI) announced a strategic partnership with Dubai-headquartered VaporVM on November 12, 2025 to expand distribution of BIO-key’s identity and biometric solutions across the Middle East and Africa. VaporVM will integrate and promote BIO-key’s PortalGuard IAM platform, Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key biometric engine, identity-bound biometrics, and certified scanners, and provide local deployment, partner enablement, and technical support. The collaboration targets enterprises and public-sector organizations operating on AWS, Azure, and GCP, aiming to combine VaporVM’s regional cloud and managed-services presence with BIO-key’s authentication technology to support secure, compliant digital transformation.

BIO-key (NASDAQ: BKYI) will showcase passwordless and identity-bound biometric authentication at Africa Tech Festival 2025, Nov 10–13 at the Cape Town International Convention Centre (CTICC), Booth H72. BIO-key and partner Altron Arrow will demonstrate Identity-Bound Biometrics (IBB), the PortalGuard® IAM platform, and Passkey:YOU™ for phoneless, tokenless access.

Visitors can meet the team and view live demonstrations aimed at enabling secure, scalable, and inclusive digital identity solutions for governments and enterprises across Africa.

BIO-key International (NASDAQ: BKYI) will host its Q3 investor call on Friday, November 14, 2025 at 10:00 a.m. ET. The company will release third-quarter results before the market opens that morning.

Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the call and a Q&A session. A live webcast and replay will be available, and the audio replay access details are provided for U.S. and international listeners.

Dial-in and webcast details will be available to investors; the webcast replay will remain accessible for three months.

BIO-key (NASDAQ: BKYI) announced a significant deployment with a major Middle East defense-sector security organisation on Nov. 7, 2025.

The solution will protect critical infrastructure and sensitive access environments using BIO-key’s biometric and multi-factor authentication, avoiding reliance on mobile devices or hardware tokens. The customer requested anonymity for security reasons. BIO-key said the contract is one of its largest regional security-sector deployments and follows a new strategic partnership with Cloud Distribution to accelerate in-country delivery and opportunities.

BIO-key (NASDAQ: BKYI) entered into a warrant inducement agreement dated Oct 27, 2025, with an existing institutional investor to induce exercise of Series A and Series B warrants originally issued Jan 15, 2025.

The investor agreed to purchase 3,091,668 shares at a reduced exercise price of $1.02 per share, producing gross proceeds of approximately $3.1 million before placement agent fees and offering expenses. Maxim Group is the exclusive placement agent.

As consideration, BIO-key will issue 6,183,336 unregistered new warrants exercisable at $1.02 per share, immediately exercisable and expiring five years from issuance, and will file an SEC registration statement covering resale of shares issuable on exercise.

BIO-key International (NASDAQ: BKYI) announced a partnership with Scandinavian distributor IT2Trust on October 27, 2025 to expand BIO-key’s identity and access management (IAM) and biometric solutions across Denmark, Sweden, Norway, and Finland.

Under the agreement, IT2Trust will distribute and support BIO-key’s full portfolio including PortalGuard (MFA, SSO), Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key, Identity-Bound Biometrics, and certified scanners PIV-Pro and EcoID III, with a focus on GDPR compliance and public sector and enterprise adoption.

BIO-key (Nasdaq: BKYI) launched the EcoID III USB fingerprint scanner on October 21, 2025, delivering FBI FAP 20, PIV, and NIBSS certifications, plus liveness detection and encrypted device-to-host communication.

EcoID III supports Windows Hello/Windows Hello for Business and FIDO2 Platform authentication, interoperates with over 30 scanners on BIO-key platforms, and offers faster captures, 360-degree placement, LED guidance, and robust performance in bright, wet, and noisy environments. BIO-key says first volume orders are shipping to government customers; availability is via BIO-key and authorized partners.

BIO-key (Nasdaq: BKYI) announced it will exhibit and present at GITEX Global in Dubai (Oct 13–17, 2025) and 19ENISE in León, Spain (Oct 14–16, 2025).

The company will demo Identity-Bound Biometrics (IBB), PortalGuard IAM, and Passkey:YOU, promote passwordless/phoneless/tokenless authentication, and pursue regional partnerships across government, healthcare, and enterprise. BIO-key will host a main-stage presentation and a business networking dinner on Oct 15 in Dubai, and exhibit at Booth 130 in León.

BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions, reported strong Q2 2025 financial results with revenue increasing 49% to $1.7M. The growth was driven by increases across all segments, with software license fees up 4% to $806K, services revenue rising to $322K, and hardware sales significantly increasing to $569K.

The company launched its BIO-key CyberDefense Initiative to target the growing global defense market, particularly in Europe where EU member states are expected to spend €350B on defense by 2026. Notable Q2 achievements include securing over $600K in follow-on orders from a Foreign Defense Ministry and establishing their first major IAM deployment with a national bank in Mozambique.

Despite the revenue growth, the company reported a net loss of ($1.17M), or ($0.20) per share, though improved from ($1.67M) in Q2'24. Gross margin was 73%, down from 77% year-over-year due to increased hardware sales.